Schedule 13G ownership disclosure
Terns Pharmaceuticals Inc
Security class unavailable · CUSIP: 880881107
Event date: 2022-08-16
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 8.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-22-095270
- Form type
- SC 13G
- Filer
- Terns Pharmaceuticals, Inc.
- CIK
- CIK 1831363
- Filed
- Aug 29, 2022
- Reporting period
- Aug 16, 2022
- Description
- Schedule 13G beneficial ownership